#USA #wearable technology #Zepp Health #Amazfit #Milpitas, California

Zepp Health Corporation Reports First Quarter 2025 Financial Results

On May 19, 2025, Zepp Health Corporation (NYSE: ZEPP) disclosed its unaudited financial performance for the first quarter of 2025. Despite facing a tough macroeconomic environment, the company demonstrated resilience, marking growth in revenue and gross margin.

Financial and Operational Highlights

For Q1 2025, Zepp Health achieved revenues of $39 million, representing a year-over-year increase, driven primarily by a 10.2% growth in the sales of Amazfit-branded products. Gross margin improved to 37.3%, higher than the previous year's 36.8%. Moreover, the company boasted a cash balance of $104 million, following the repayment of $11.5 million in short-term debt over the quarter.

In view of the current landscape, Zepp Health has proactively adapted its dual-sourcing supply chain strategy with production facilities in both China and Vietnam, a move that has helped navigate recent tariff reductions between the U.S. and China.

Anticipated Growth

The company’s management forecasts net revenues for Q2 2025 to range between $50 million and $55 million, indicating an increase of 23% to 35% compared to the previous year’s figure of $40.6 million for Q2 2024.

Mr. Wayne Huang, Chairman and CEO, commented, “We are pleased to see that our Amazfit revenue grew amid challenging market conditions as we sharpen our operational model for sustained resilience.” The successful launch of watches like the Amazfit Active 2 and Bip 6, which have received high accolades on platforms like Amazon and Reddit, significantly contributed to this upward trend in revenue.

Product Innovations and Market Strategy

Zepp Health continues to leverage open-source technologies, enhancing its products with innovations such as the improved Zepp Flow voice command response. This has led to a 17-fold improvement in speed, showcasing the company’s commitment to advancing technology in its smartwatches. By integrating hybrid AI solutions, the company managed to reduce food recognition costs in its app by 90%, thus widening the service area and enhancing user engagement.

The company has also expanded its reach within the HYROX community through active participation in sports events globally, which has led to partnerships with prominent athletes like Olympic medalist Gabby Thomas. These efforts are intended to strengthen Zepp’s brand presence and foster closer connections with its user base.

Financial Insights

Despite the positive revenue trends, the company reported a net loss of $19.7 million for Q1 2025, as well as an adjusted net loss of $18.1 million. This performance reflects the traditional lowest sales season for consumer electronics and variance in market conditions. However, with a cash position of $104 million, Zepp Health maintains a healthy liquidity profile to pursue growth initiatives.

Mr. Leon Deng, CFO of Zepp Health, stated, “The revenue growth reflects sustained momentum in our primary markets, fueled by successful product launches that exceeded expectations.” The financial results suggest that the company's ongoing strategies around product innovation and market expansion are beginning to pay off after a period of transformation.

Moreover, the company's focus on research and development remains vigorous, indicated by $12.4 million allocated but managed efficiently, showcasing dedication to long-term competitiveness in wearable technology.

Looking Ahead

Going forward, Zepp Health expects the market to recover and grow, planning several new product launches and exploring further partnerships to broaden its market footprint. The company remains committed to navigating external challenges and optimizing its supply chain, with a focus on delivering unique AI-driven experiences that can solidify its lead in the wearable sector.

In summary, Zepp Health Corporation’s strong first-quarter results set a promising tone for the rest of 2025, showcasing both growth and a robust market strategy that leverages innovative technologies and partnerships to create a formidable presence in the health technology industry.

• ---

For additional details or to listen to the management discussion regarding this quarter's performance, please follow their conference call, where they will provide deeper insights and answer investor inquiries.